Silimar, tablets 100 mg 30 pcs

Hepatoprotective drug of plant origin.

Hepatoprotective and antitoxic effect.

Therapeutic effect is due to the effect on hepatocyte metabolism.

Activates synthesis of proteins and enzymes in hepatocytes, stabilizing effect on hepatocyte membrane, inhibits penetration of toxins into liver cells, inhibits dystrophic and potentiates regenerative processes in the liver.

Indications

Toxic liver damage;
chronic hepatitis;
liver cirrhosis (as part of complex therapy);
condition after hepatitis;
for the purpose of prevention in case of chronic intoxication (including occupational), long-term use of medications and alcohol.

Pharmacological effect

Hepatoprotective drug of plant origin.

Has hepatoprotective and antitoxic effects.

The therapeutic effect is due to the effect on the metabolism of hepatocytes.

Activates the synthesis of proteins and enzymes in hepatocytes, has a stabilizing effect on the hepatocyte membrane, inhibits the penetration of toxins into liver cells, inhibits dystrophic and potentiates regenerative processes in the liver.

Special instructions

Use in pediatrics

It is not recommended to prescribe the drug to children under 12 years of age.

Active ingredient

Milk thistle fruit extract

Composition

Active ingredients:

milk thistle fruit extract – 100 mg.

Excipients:

lactose,

potato starch,

magnesium stearate.

Contraindications

Hypersensitivity to the components of the drug.

Side Effects

Possibly allergic reactions.

In some cases – a laxative effect.

Interaction

Data on drug interactions with Silymar are not provided.

Overdose

Data on overdose of the drug Silymar are not provided.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

5 years

Manufacturer

Pharmcenter VILAR JSC, Russia